In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
EPIX and Schering MRI agents alliance
EPIX grants patent license for Schering's Eovist
EPIX and Predix Pharmaceuticals complete merger
Mallinckrodt signs Dexedine promotion agreement with SmithKline Beecham
EPIX Pharmaceuticals Achieves Discovery Milestone in Collaboration with GlaxoSmithKline
Mallinckrodt receives FDA approval
Schering AG and AstraZeneca form strategic alliance to develop novel anti-cancer drug
Mallinckrodt Baker and Rubicon Research Sign Agreement for Performance Excipient Development
Dyax Announces Second Peptide Discovery Collaboration with EPIX Pharmaceuticals
Mallinckrodt to supply peptide to Trimeris for novel AIDS therapeutic
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
